StockData

AVAI Bio, Inc. (AVAI) stock

AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026Market cap $17.24MP/E –Yield –

AVAI Bio r&d expenses

Research and development expenses are spending on new products and technology.

AVAI Bio's R&D Expenses for the twelve months ending Mar 31, 2020 was $27.04K. For fiscal 2026 it was $15.00K, down 44.5% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$15.00K-44.5%
FY2020Mar 31, 2020$27.04K–
FY2019Mar 31, 2019$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ4 2025Dec 31, 2025$0–
Q2 FY2026CQ3 2025Sep 30, 2025$23.80K–
Q4 FY2020CQ1 2020Mar 31, 2020$0–
Q3 FY2020CQ4 2019Dec 31, 2019$0–
Q4 FY2019CQ1 2019Mar 31, 2019$0–
Q3 FY2019CQ4 2018Dec 31, 2018$0–
Q2 FY2019CQ3 2018Sep 30, 2018$0–

More AVAI Bio figures

See a number that looks wrong?